|
Pharmacological Group: Antineoplastic, Active Principle: Transretinoic Acid - Tretinoin, Pharmaceutical Form: Capsule, Concentration/Dosage: 10, Unit: Mg, Volume: N/A, Presentation: N/A, N/A, Active Principle: Carbonatin, Pharmaceutical Form: Injectable Solution, Concentration/Dosage: 10Mg/Ml, Unit: Mg/Ml, Volume: 45 Ml, Presentation: Ampoule Bottle, Active Principle: Idarrubicin Hydrochloride, Pharmaceutical Form: Injectable Po, Presentation: Vial, Pharmacological Group: Antineoplastic- Anti-Retorals, Active Principle: Melphalan, Concentration / Dosage: 50, Unit: Mg, Volume: Not Applicable: Not Applicable, Not Applicable, Not Applicable, Accessory: Not Applicable Pharmacological Group: Antidotes And Antagonists, Active Principle: Mercattoetano (Mesna 2), Concentration / Dosing: 100, Volume: 4Ml, Presentation: Ampolo, Active Principle: Mercattoethane (Mesna), Pharmaceutical Form: Compressed, Concentration / Dosage: 400, Form Supply: Unit, Active Principle, Sodium Methotrexate, Concentration / Dosage: 500, Volume: 20Ml, Pharmacological Group: Not Framed In Specific Therapy Class, Active Principle: Picrixafor, Concentration / Dosage: 20, Volume: 1, 2Ml, Pharmacological Group: Antineoplastic (Science Kinase Inhibitor), Active Principle: Ponatinib Hydrochloride, Pharmaceutical Form, Concentration, Concentration, Concentration, Concentration, Concentration / Dosage: 15, Active Principle: Ruxolitinibe
|
